London Daily

Focus on the big picture.
Wednesday, Jul 02, 2025

UK approves first COVID antiviral pill for use

UK approves first COVID antiviral pill for use

The United Kingdom (UK) has become the first country globally to approve a COVID-19 antiviral pill jointly developed by US-based Merck & Co Inc and Ridgeback Biotherapeutics.

The potentially game-changing drug, molnupriavir, was recommended by Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) for use in people who suffer from mild to moderate symptoms of COVID-19 and have at least one risk factor for developing severe illness which includes obesity, Type 2 diabetes and heart disease.

The drug will be administered to patients who test positive for the coronavirus and within five days of the onset of symptoms.

The MHRA said this determination is made by clinical data gathered throughout the trial phases of the drug.

The approval for the pill is the first for an oral antiviral COVID-19 treatment worldwide and it will be the very first time the drug will be administered on a wide-scale community level.

FDA to review drug’s safety this month


Food and Drug Administration (FDA) advisers from the United States are expected to meet on November 30 of this month to review the drug’s safety and efficacy and vote on whether the drug should be authorised for use in the US.

The pill, which is expected to be branded as Lageviro in the UK, has been designed to reprogram the genetic coding of the COVID-19 and introduce errors. The pill will be taken twice a day for at least five days.

The pill will be a welcomed addition for many people across the world as treatments to tackle the impacts of the virus are mainly focused on vaccines.

Also, the data by Merck’s on the pill has shown it could slash the possibility of dying or being severely hospitalised by COVID-19 by 50 percent.

Wider roll-out


A wider rollout will follow if it is clinically and cost-effective in reducing hospitalisations and death.

If the pill proves to be successful in the UK, it could mean good news for the Virgin Islands and other Caribbean states as they try to deal with the impacts of the pandemic. While the Virgin Islands has had higher uptake of the vaccines among citizens in comparison to other countries in the Caribbean, there is still some level of vaccine hesitancy in the territory.

However, this antiviral treatment provides an alternative for the vaccine. The statistics show that a little more than 52 percent of the population is fully vaccinated while six per cent has received its first dose of a two-dose vaccine.

While many people may have questions surrounding the validity of the antiviral drug because other drugs in the same class as molnupiravir has been linked to birth defects in animals, Merck & Co Inc said its testing data on animals indicate it is completely safe for use. However, the data is not yet made available to the public.

Newsletter

Related Articles

0:00
0:00
Close
Poland Implements Border Checks Amid Growing Migration Tensions
Political Dispute Escalates Between Trump and Musk
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
US Senate Votes to Remove AI Regulation Moratorium from Domestic Policy Bill
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
Jury Deliberations in Diddy Trial Yield Partial Verdict in Serious Criminal Charges
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
King Charles Plans Significant Role for Prince Harry in Coronation
Two Chinese Nationals Arrested for Espionage Activities Against U.S. Navy
Amazon Reaches Major Automation Milestone with Over One Million Robots
Extreme Heat Wave Sweeps Across Europe, Hitting Record Temperatures
Meta Announces Formation of Ambitious AI Unit, Meta Superintelligence Labs
Robots Compete in Football Tournament in China Amid Injuries
Trump Administration Considers Withdrawal of Funding for Hospitals Providing Gender Treatment to Minors
Texas Enacts Law Allowing Gold and Silver Transactions
China Unveils Miniature Insect-Like Surveillance Drone
OpenAI Secures Multimillion-Dollar AI Contracts with Pentagon, India, and Grab
Marc Marquez Claims Victory at Dutch Grand Prix Amidst Family Misfortune
Germany Votes to Suspend Family Reunification for Asylum Seekers
Elon Musk Critiques Senate Budget Proposal Over Job Losses and Strategic Risks
Los Angeles Riots ended with Federal Investigations into Funding
Budapest Pride Parade Draws 200,000 Participants Amid Government Ban
Southern Europe Experiences Extreme Heat
Xiaomi's YU7 SUV Launch Garners Record Pre-Orders Amid Market Challenges
Jeff Bezos and Lauren Sanchez's Lavish Wedding in Venice
Russia Launches Largest Air Assault on Ukraine Since Invasion
Education Secretary Announces Overhaul of Complaints System Amid Rising Parental Grievances
Massive Anti-Government Protests Erupt in Belgrade
Trump Ends Trade Talks with Canada Over Digital Services Tax
UK Government Softens Welfare Reform Plans Amid Labour Party Rebellion
Labour Faces Rebellion Over Disability Benefit Reforms Ahead of Key Vote
Jeff Bezos and Lauren Sánchez Host Lavish Wedding in Venice Amid Protests
Trump Asserts Readiness for Further Strikes on Iran Amid Nuclear Tensions
North Korea to Open New Beach Resort to Boost Tourism Economy
UK Labour Party Faces Internal Tensions Over Welfare Reforms
Andrew Cuomo Hints at Potential November Comeback Amid Democratic Primary Results
Curtis Sliwa Champions His Vision for New York City Amid Rising Crime Concerns
Federal Reserve Proposes Changes to Capital Rule Affecting Major Banks
EU TO HUNGARY: LET THEM PRIDE OR PREP FOR SHADE. ORBÁN TO EU: STAY IN YOUR LANE AND FIX YOUR OWN MESS.
Trump Escalates Criticism of Media Over Iran Strike Coverage
Trump Announces Upcoming US-Iran Meeting Amid Controversial Airstrikes
Trump Moves to Reshape Middle East Following Israel-Iran Conflict
Big Four Accounting Firms Fined in Exam Cheating Scandal
NATO Members Agree to 5% Defense Spending Target by 2035
Australia's Star Casino Secures $195 Million Rescue Package Amid Challenges
UK to Enhance Nuclear Capabilities with Acquisition of F-35A Fighter Jets
Russian Shadow Payments via Cryptocurrency Reach $9 Billion
Explosions Rock Doha as Iranian Missiles Target Qatar
“You Have 12 Hours to Flee”: Israeli Threat Campaign Targets Surviving Iranian Officials
×